Article
The Endocannabinoid System: A Bridge between Alzheimer’s Disease and Gut Microbiota
8 Sept 2021
Abstract excerpt
Alzheimer's disease (AD) is a neurodegenerative disease that progresses from mild cognitive impairment to severe dementia over time. The main clinical hallmarks of the disease (e.g., beta-amyloid plaques and neurofibrillary tangles) begin during preclinical AD when cognitive deficits are not yet apparent. Hence, a more profound understanding of AD pathogenesis is needed to develop new therapeutic strategies. In...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
